Home · Guides · What to Expect in Your First 6 Weeks on GLP-1

What to Expect in Your First 6 Weeks on GLP-1

Week-by-week timeline of weight loss, side effects, and titration on semaglutide and tirzepatide.

Released: Last reviewed:

The first six weeks on GLP-1 therapy follow a fairly predictable arc. This is the realistic week-by-week version — not the social-media version.

Week 1: 0.25 mg semaglutide (or 2.5 mg tirzepatide)

Most patients feel essentially nothing the first three days. Day four through seven, two things often appear: mild nausea (especially after meals that include high-fat content) and a noticeable reduction in food noise. Weight change is typically 0–1 lb, and most of that is water from reduced carbohydrate intake.

Week 2

Side effects either stabilize or get slightly worse. The nausea-prone subset of patients (roughly 30%) will report constipation, occasional heartburn, and what's colloquially called "sulfur burps" — a side effect caused by delayed gastric emptying interacting with sulfur-containing foods. Mitigations are practical: smaller meals, more water, and avoiding very high-fat or very high-fiber meals close together.

Weeks 3–4: titration to 0.5 mg semaglutide (or 5 mg tirzepatide)

This is where most patients first feel the drug clearly. Appetite suppression is meaningful. Many patients report they have to remind themselves to eat. Weight loss accelerates — a typical range for weeks 3 and 4 combined is 3–6 lbs. Side effects may briefly worsen at the dose escalation point and then stabilize within a few days.

Weeks 5–6

By the end of week 6, most patients are 6–12 lbs down from baseline. The distribution is wide — high responders may be 15+ lbs down, and low responders may be 4 lbs down. This early variation is not strongly predictive of total response by month six.

Muscle mass at six weeks

Without resistance training, approximately 25–40% of weight lost in the first six weeks is lean mass. With resistance training plus adequate protein (1.6 g/kg body weight as a floor), that drops dramatically. This is the single most underemphasized intervention in the first six weeks. See our muscle preservation guide.

When to call your provider

  • Persistent vomiting for more than 24 hours — especially without obvious cause
  • Severe upper abdominal pain radiating to the back (rule out pancreatitis)
  • Inability to keep fluids down — dehydration risk
  • Symptoms of low blood sugar if you're also on insulin or sulfonylureas (combination dosing should be reviewed)

What to expect, summarized

Six weeks in, most patients are 6–12 lbs down, food noise is meaningfully reduced, and dose has stepped up to 0.5 mg semaglutide or 5 mg tirzepatide. Tolerance to GI side effects builds over the first 8–10 weeks. The biggest determinant of how the next six months look is whether resistance training and adequate protein are dialed in now.

Editor's pick for this category

NexLife is our editorial pick (94/100 on the v4.1 methodology). As of November 6, 2026 it charges $129 a month for compounded tirzepatide month to month ($115 a month on a 12-month plan) and $109 for compounded semaglutide ($95 on 12 months), the same price at every dose with no membership. Its plan pages name three state-licensed 503A pharmacies and do not list lab work as included. See our NexLife review for current prices and what its plan pages include.

Read the NexLife review →

Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)
Last medically reviewed: November 8, 2026 · This page is informational and does not constitute medical advice.

Related guides